Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats

Acta Physiologica

Volumn 217, Issue 2, 2016, Pages 130-140

  Panveloski Costa, A C ^a   Silva Teixeira, S ^a   Ribeiro, I M R ^a   Serrano Nascimento, C ^a   das Neves, R X ^a   Favaro, R R ^a   Seelaender, M ^a   Antunes, V R ^a   Nunes, M T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Diabetes mellitus; Triiodothyronine

Indexed keywords

ALLOXAN; CYTOKINE; INTERLEUKIN 6; LIOTHYRONINE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; GLUCOSE BLOOD LEVEL; INFLAMMASOME; INSULIN;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL INFILTRATION; GLUCOSE BLOOD LEVEL; HEART RATE; INFLAMMATORY CELL; INSULIN RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; THYROID FUNCTION; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; IMMUNOLOGY; INSULIN RESISTANCE; METABOLISM; TREATMENT OUTCOME; WISTAR RAT;

ADIPOSE TISSUE; ALLOXAN; ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; INFLAMMASOMES; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; RATS, WISTAR; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 84957837657     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12647     Document Type: Article

References (45)

1. Antunes, T.T., Gagnon, A., Bell, A. & Sorisky, A. 2005. Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway. Obes Res 13, 2066-2071.
2. Antunes, T.T., Gagnon, A., Langille, M.L. & Sorisky, A. 2008. Thyroid-stimulating hormone induces interleukin-6 release from human adipocytes through activation of the nuclear factor-kappa B pathway. Endocrinology 149, 3062-3066.
3. Bastard, J.P., Maachi, M., Van Nhieu, J.T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.J., Capeau, J. & Hainque, B. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87, 2084-2089.
4. Baxter, J.D. & Webb, P. 2009. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 8, 308-320.
5. Berry, M.J., Kates, A.L. & Larsen, P.R. 1990. Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol Endocrinol 4, 743-748.
6. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J. & Larsen, P.R. 2002. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23, 38-89.
7. Bjornstad, P., Snell-Bergeon, J.K., Nadeau, K.J. & Maahs, D.M. 2015. Insulin sensitivity and complications in type 1 diabetes: new insights. World J Diabetes 15, 8-16.
8. Bonora, E., Moghetti, P., Zancanaro, C., Cigolini, M., Querena, M., Cacciatori, V., Corgnati, A. & Muggeo, M. 1989. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68, 374-378.
9. Brunetto, E.L., Teixeira, S.S., Giannocco, G., Machado, U.F. & Nunes, M.T. 2012. T3 rapidly increases SLC2A4 gene expression and GLUT4 trafficking to the plasma membrane in skeletal muscle of rat and improves glucose homeostasis. Thyroid 22, 70-79.
10. Calil-Silveira, J., Serrano-Nascimento, C. & Nunes, M.T. 2012. Iodide treatment acutely increases pendrin (SLC26A4) mRNA expression in the rat thyroid and the PCCl3 thyroid cell line by transcriptional mechanisms. Mol Cell Endocrinol 350, 118-124.
11. Dai, G., Levy, O. & Carrasco, N. 1996. Cloning and characterization of the thyroid iodide transporter. Nature 379, 458-460.
12. Dimitriadis, G.D. & Raptis, S.A. 2001. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109, 225-239.
13. Dimitriadis, G., Mitrou, P., Lambadiari, V., Boutati, E., Maratou, E., Panagiotakos, D.B., Koukkou, E., Tzanela, M., Thalassinos, N. & Raptis, S.A. 2006. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 91, 4930-4937.
14. Elshal, M.F. & McCoy, J.P. 2006. Multiplex bead array assay: performance evaluation and comparison of sensitivity to ELISA. Methods 38, 317-323.
15. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J. & Paquot, N. 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105, 141-150.
16. Feingold, K.R. & Grunfeld, C. 1987. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 80, 184-190.
17. Gagnon, A., Langille, M.L., Chaker, S., Antunes, T.T., Durand, J. & Sorisky, A. 2014. TSH signaling pathways that regulate MCP-1 in human differentiated adipocytes. Metabolism 63, 812-821.
18. Gonzalez, C., Montoya, E. & Jolin, T. 1980. Effect of streptozotocin diabetes on the hypothalamic-pituitary-thyroid axis in the rat. Endocrinology 107, 2099-2103.
19. de Graaff, L.C., Martín-Martorell, P., Baan, J., Ballieux, B., Smit, J.W. & Radder, J.K. 2011. Long-term follow-up of organ-specific antibodies and related organ dysfunction in type 1 diabetes mellitus. Neth J Med 69, 66-71.
20. Huber, A., Menconi, F., Corathers, S., Jacobson, E.M. & Tomer, Y. 2008. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29, 697-725.
21. Joffe, B.I. & Distiller, L.A. 2014. Diabetes mellitus and hypothyroidism: strange bedfellows or mutual companions? World J Diabetes 15, 901-904.
22. Kahaly, G.J. & Dillmann, W.H. 2005. Thyroid hormone action in the heart. Endocr Rev 26, 704-728.
23. Kim, K.K., Park, K.S., Song, S.B. & Kim, K.E. 2010. Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I. J Biol Chem 285, 32003-32011.
24. Klieverik, L.P., Janssen, S.F., Van Riel, A., Foppen, E., Bisschop, P.H., Serlie, M.J., Boelen, A., Ackermans, M.T., Sauerwein, H.P., Fliers, E. & Kalsbeek, A. 2009. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proc Natl Acad Sci USA 106, 5966-5671.
25. Lasa, M., Gil-Araujo, B., Palafox, M. & Aranda, A. 2010. Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1. Mol Endocrinol 24, 412-422.
26. Lenzen, S. 2007. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51, 216-226.
27. Li, T., Francl, J.M., Boehme, S., Ochoa, A., Zhang, Y., Klaassen, C.D., Erickson, S.K. & Chiang, J.Y. 2012. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem 287, 1861-1873.
28. -ΔΔCt method. Methods 25, 402-408.
29. McArdle, M.A., Finucane, O.M., Connaughton, R.M., McMorrow, A.M. & Roche, H.M. 2013. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) 10, 4-52.
30. Mintz, G., Pizzarello, R. & Klein, I. 1991. Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metabol 73, 146-150.
31. Pang, T.T. & Narendran, P. 2008. Addressing insulin resistance in type 1 diabetes. Diabet Med 25, 1015-1024.
32. Pantos, C., Mourouzis, I., Markakis, K., Tsagoulis, N., Panagiotou, M. & Cokkinos, D.V. 2008. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol 103, 308-318.
33. Romero-Calvo, I., Ocón, B., Martínez-Moya, P., Suárez, M.D., Zarzuelo, A., Martínez-Augustin, O. & de Medina, F.S. 2010. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401, 318-320.
34. Rondeel, J.M., de Greef, W.J., Heide, R. & Visser, T.J. 1992. Hypothalamo-hypophysial-thyroid axis in streptozotocin-induced diabetes. Endocrinology 130, 216-220.
35. Salil, G., Nevin, K.G. & Rajamohan, T. 2011. Arginine rich coconut kernel protein modulates diabetes in alloxan treated rats. Chem Biol Interact 189, 107-111.
36. Santos, M.C., Louzada, R.A., Souza, E.C., Fortunato, R.S., Vasconcelos, A.L., Souza, K.L., Castro, J.P., Carvalho, D.P. & Ferreira, A.C. 2013. Diabetes mellitus increases reactive oxygen species production in the thyroid of male rats. Endocrinology 154, 1361-1372.
37. Schram, M.T., Chaturvedi, N., Schalkwijk, C.G., Fuller, J.H. & Stehouwer, C.D. 2005. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study. Diabetologia 48, 370-378.
38. Serrano-Nascimento, C., Calil-Silveira, J. & Nunes, M.T. 2010. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. Am J Physiol Cell Physiol 298, 893-899.
39. Tang, W., Yuan, M., Wang, R., Yang, Y., Wang, C., Oses-Prieto, J.A., Kim, T.W., Zhou, H.W., Deng, Z., Gampala, S.S. et al. 2011. PP2A activates brassinosteroid-responsive gene expression and plant growth by dephosphorylating BZR1. Nat Cell Biol 13, 124-131.
40. Torrance, C.J., Devente, J.E., Jones, J.P. & Dohm, G.L. 1997. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology 138, 1204-1214.
41. Uchida, K., Takase, H., Kadowaki, M., Nomura, Y., Matsubara, T. & Takeuchi, N. 1979. Altered bile acid metabolism in alloxan diabetic rats. Jpn J Pharmacol 29, 553-562.
42. Uchida, K., Makino, S. & Akiyoshi, T. 1985. Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice. Diabetes 34, 79-83.
43. Umpierrez, G.E., Latif, K.A., Murphy, M.B., Lambeth, H.C., Stentz, F., Bush, A. & Kitabchi, A.E. 2003. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 26, 1181-1185.
44. Weber, K.T. 1997. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol 17, 467-491.
45. Zhang, Y.J., Zhao, W., Zhu, M.Y., Tang, S.S. & Zhang, H. 2013. Thyroid-stimulating hormone induces the secretion of tumor necrosis factor-alpha from 3T3-L1 adipocytes via a protein kinase A-dependent pathway. Exp Clin Endocrinol Diabetes 121, 488-493.